You are here:

Translational Research Initiative for Hearing (TRIH)

 Components of TRIH

Advancing medicines to protect and restore hearing and silence tinnitus by funding translational research, creating partnerships, providing market insight and engaging patients.

In the UK there are 10 million people with a hearing loss and 6 million people who live with tinnitus. Despite this high medical need, there are no clinically approved treatments to halt or prevent hearing loss and no pharmaceutical treatment that can safely and effectively silence tinnitus.

TRIH aims to change this by supporting translational research – the phase of research where promising discoveries are moved from the laboratory into clinical trials. There are four key components to TRIH:

  • Funding: supporting international translational research in hearing loss and tinnitus.
  • Consultancy: providing expert advice and guidance to industry and investors on hearing loss and tinnitus research and development, and market opportunities.
  • Partners: helping industry to work with leading research groups and therapy area experts around the world to accelerate the development of new therapeutics.
  • Patients: helping people with hearing loss and tinnitus get involved in research.

More information about our TRIH services can be found in our TRIH Brochure or by contacting

Action on Hearing Loss funded researcher working in a laboratory.


Our international TRIH grant scheme funds translational research projects, within both academic research institutes and small-medium enterprises (SMEs).
Find out more

Graphic showing TRIH components


We provide expert advice and guidance to industry on hearing loss and tinnitus research and development, and market opportunities.
Find out more

TRIH partners structure


TRIH partners are a consortium of organisations that support the development of treatments for hearing loss and tinnitus
Find out more

An elderly man having his ears checked by an audiologist.


As a membership organisation we can facilitate and promote the engagement of patients in research
Find out more

Action on Hearing Loss staff talking to a supporter at a conference.

Get involved in Clinical Research

Clinical trials are essential for ensuring the development of the most effective and safest therapies, and need the support and involvement of people with hearing loss and tinnitus.
Find out more

Two people talking at a conference.

Support TRIH

TRIH enables us to invest in the initial high-risk stages of developing new hearing loss and tinnitus treatments but, we can’t do this without your support
Find out more

hearing matters